259 related articles for article (PubMed ID: 36672378)
1. The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia.
Ziętara KJ; Lejman J; Wojciechowska K; Lejman M
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672378
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.
Anelli L; Zagaria A; Specchia G; Musto P; Albano F
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281210
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review.
Szczepanek J
World J Clin Oncol; 2020 Jun; 11(6):348-369. PubMed ID: 32855905
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of microRNAs in acute lymphoblastic leukemia and their clinical prospects.
Deng W; Pan M; Zhu S; Chao R; Wang L
Expert Rev Hematol; 2021 Nov; 14(11):987-992. PubMed ID: 34784832
[TBL] [Abstract][Full Text] [Related]
8. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.
Kubota H; Ueno H; Tasaka K; Isobe T; Saida S; Kato I; Umeda K; Hiwatari M; Hasegawa D; Imamura T; Kakiuchi N; Nannya Y; Ogawa S; Hiramatsu H; Takita J
Blood Adv; 2024 Mar; 8(5):1258-1271. PubMed ID: 38127276
[TBL] [Abstract][Full Text] [Related]
9. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
10. T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers.
Drobna M; Szarzyńska-Zawadzka B; Dawidowska M
Blood Rev; 2018 Nov; 32(6):457-472. PubMed ID: 29703513
[TBL] [Abstract][Full Text] [Related]
11. MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.
Mendiola-Soto DK; Bárcenas-López DA; Pérez-Amado CJ; Cruz-Miranda GM; Mejía-Aranguré JM; Ramírez-Bello J; Hidalgo-Miranda A; Jiménez-Morales S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982511
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
Pouyanrad S; Rahgozar S; Ghodousi ES
Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
[TBL] [Abstract][Full Text] [Related]
13. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
15. Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.
Ultimo S; Martelli AM; Zauli G; Vitale M; Calin GA; Neri LM
J Cell Physiol; 2018 Aug; 233(8):5642-5654. PubMed ID: 29154447
[TBL] [Abstract][Full Text] [Related]
16. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.
Rashed WM; Hamza MM; Matboli M; Salem SI
Cancer Metastasis Rev; 2019 Dec; 38(4):771-782. PubMed ID: 31807971
[TBL] [Abstract][Full Text] [Related]
18. miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic review.
Gutierrez-Camino A; Garcia-Obregon S; Lopez-Lopez E; Astigarraga I; Garcia-Orad A
Epigenomics; 2020 Jan; 12(1):69-80. PubMed ID: 31833405
[TBL] [Abstract][Full Text] [Related]
19. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of miRNA genes in acute leukemia.
Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]